Showing results (151-160 of 386) with videos related to
Sort By:
Pageof 39
The Lancet. Oncology|July 6, 2017
Methods to reduce postoperative surgical site infections after head and neck oncology surgeryRichard B Cannon, Jeffrey J Houlton, Eduardo Mendez, et al.Bioinformatics (Oxford, England)|August 24, 2024
Pandagma: a tool for identifying pan-gene sets and gene families at desired evolutionary depths and accommodating whole-genome duplicationsSteven B Cannon, Hyun-Oh Lee, Nathan T Weeks, et al.Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|May 7, 2016
Long-term Outcomes After Middle Fossa Approach for Traumatic Facial Nerve ParalysisRichard B Cannon, Rhett S Thomson, Clough Shelton, et al.Case Reports in Plastic Surgery & Hand Surgery|September 22, 2025
3D-guided cadaveric fibula reconstruction for pediatric infratemporal solitary fibrous tumorJacob Beiriger, Nilam D Patel, Hilary C McCrary, et al.Gastroenterology|December 1, 1975
Gastric emptying and small intestinal mucosal injury in ratsT H Kent, B Cannon, J A Reynolds, et al.Nucleic Acids Research|December 17, 2009
SoyBase, the USDA-ARS soybean genetics and genomics databaseDavid Grant, Rex T Nelson, Steven B Cannon, et al.Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|July 25, 2014
Facial nerve outcomes after middle fossa decompression for Bell's palsyRichard B Cannon, Richard K Gurgel, Frank M Warren, et al.Scandinavian Journal of Immunology|September 1, 1984
Immune characteristics of the beige-nude mouse. A model for studying immune surveillanceO Fodstad, C T Hansen, G B Cannon, et al.Journal of Veterinary Internal Medicine|September 12, 2017
Desoxycorticosterone Pivalate Duration of Action and Individualized Dosing Intervals in Dogs with Primary HypoadrenocorticismJ A Jaffey, P Nurre, A B Cannon, et al.Journal of Drug Targeting|January 1, 1996
Alternate drug delivery routes for A-71623, a potent cholecystokinin-A receptor agonist tetrapeptideJ B Cannon, L A Adjei, M Y Lu, et al.Pageof 39